Real-World Evidence on Prognostic Value of MRD in Multiple Myeloma Using Flow Cytometry publication / By David Žihala
Deubiquitinase BAP1 is crucial for surface expression of T cell receptor (TCR) complex, T cell-B cell conjugate formation, and T cell activation publication / By David Žihala
Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma publication / By Serafim Nenarokov
Targeting CD38 by isatuximab and a CD38/CD3xCD28 trispecific T-cell engager in old patients with acute myeloid leukemia publication / By Serafim Nenarokov
Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors publication / By David Žihala
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies publication / By David Žihala
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma publication / By David Žihala
Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics publication / By David Žihala
Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma publication / By David Žihala
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma publication / By David Žihala
